Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
<0.09%
General Information
Version
8
Revision date
2015-12-11
Product name
DRI Amphetamine, DRI Barbiturate, DRI Benzodiazepine, DRI Cocaine
Product Synonyms
0017 DRI® Amphetamines Assay (100 mL)
1.2.1 Relevant identified uses
In vitro diagnostic kit Criminal, Forensic & Justice Use kit
Emergency telephone
1-(800) 424-9300 (US and 46500 Kato Road
Icons in SDS
Company Information
company name
Microgenics Corporation
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Globally Harmonized Respiratory Sensitizer - Category 1. Skin Sensitizer - Category 1. System [GHS] Other/Supplemental Mixture not yet fully tested.
2.2 Label elements
10018486SDS, DRI® Technology Assays SDS Revision Date: 11 December 2015, Version 8 Page 2 of 15 ... continued GHS hazard pictogram
Signal word
Danger
Hazard statements
H317 - May cause allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. GHS precautionary P261 - Avoid breathing mist or vapor. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective gloves/eye protection/ face protection. P285 - In case of inadequate ventilation wear respiratory protection. P302 + P352 - If on skin: Wash with plenty of soap and water. P304 + P341 - IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P363 - Wash contaminated clothing before reuse. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations.
2.3 Other hazards
The potential health hazards associated with exposure/handling of this mixture are unknown; no data specific for the mixture were identified. The following data describe the hazards of individual ingredients, where applicable. Because the mixture contains a protein (bovine serum albumin) it may cause an allergic skin or respiratory reaction (e.g., potential to cause anaphylaxis). In a workplace setting, the likelihood of systemic effects following accidental ingestion is low, due to the rapid breakdown of proteins in the digestive tract. Bovine serum albumin has been associated with occupational sensitization. Although antibody particles are fairly large proteins, it is not known if systemic effects can occur following accidental inhalation. Proteins, in general, can cause skin and/or respiratory sensitization. Material produced in compliance with USDA and/or CPMP/BWP/1230/98 (Guidance on Minimizing the Risk of Transmitting Animal 10018486SDS, DRI® Technology Assays SDS Revision Date: 11 December 2015, Version 8 Page 3 of 15 ... continued Other hazards ...continued Spongiform Encephalopathy Agents via Medicinal Products). This is a CPMP/ BWP/1230/98 Category IV material: it does not contain nor is it derived from specified risk materials as defined in Commission decision 97/534/EC (or successive amendments). Note This mixture is classified as hazardous according to Directive 1999/45/EC,